Français
ItalianoBond Gilead Sciences 4.75% ( US375558BD48 ) in USD
| Issuer | Gilead Sciences | ||||||||||||||||||||||||||||||||
| Market price |  90.86 % ▲ |
||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||
| ISIN code |
 US375558BD48 ( in USD )
|
||||||||||||||||||||||||||||||||
| Interest rate | 4.75% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||
| Maturity | 01/03/2046 | ||||||||||||||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||
| Total amount | 2 250 000 000 USD | ||||||||||||||||||||||||||||||||
| Cusip | 375558BD4 | ||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Next Coupon | 01/09/2026 ( In 6 days ) | ||||||||||||||||||||||||||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BD48, pays a coupon of 4.75% per year. The coupons are paid 2 times per year and the Bond maturity is 01/03/2046 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BD48, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BD48, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||